Skip to main content
. 2021 Nov 4:10.4155/bio-2021-0190. doi: 10.4155/bio-2021-0190

Figure 2. The frequency distribution of logarithmic transformed (Log10) differences between the ECL immunoassay and the LC-MRM-MS assay for casirivimab and imdevimab.

Figure 2.

The D'Agostino and Pearson test for normal distribution (A) for casirivimab (p = 0.2394) and (B) for imdevimab (p = 0.2099).